Related Experiment Video

Updated: Apr 8, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

7.9K

Bacterial meningitis: insights into pathogenesis and evaluation of new treatment options: a perspective from

Fabian D Liechti1, Denis Grandgirard1, Stephen L Leib1,2

  • 1Neuroinfection Laboratory, Institute for Infectious Diseases, University of Bern, Friedbühlstr. 51, CH-3010 Bern, Switzerland.

Future Microbiology
|June 30, 2015
PubMed

Insights

Bacterial meningitis causes severe brain damage and death. Research is exploring new treatments, including anti-inflammatory drugs and regenerative therapies, to improve outcomes for patients with this serious infection.

Area of Science:

  • Neuroscience
  • Infectious Diseases
  • Regenerative Medicine

Background:

  • Bacterial meningitis leads to high mortality and morbidity.
  • Inflammatory responses to bacterial components cause brain damage, including cortical necrosis, inner ear damage, and hippocampal apoptosis.
  • The hippocampal dentate gyrus, crucial for memory and containing stem cells, shows potential for regeneration.

Purpose of the Study:

  • To review adjuvant therapies for bacterial meningitis.
  • To explore interventions targeting inflammation and brain injury.
  • To highlight emerging research in regenerative processes for meningitis recovery.

Main Methods:

  • Evaluation of animal models of bacterial meningitis.
  • Assessment of anti-inflammatory agents (e.g., dexamethasone).
  • Investigation of neuroprotective strategies (e.g., nonbacteriolytic antibiotics, metalloproteinase inhibitors, immunomodulators like granulocyte colony-stimulating factor).

Main Results:

  • Adjuvant therapies like dexamethasone can reduce inflammation.
  • Neuroprotective agents show promise in mitigating brain injury.
  • Regenerative approaches are a growing focus in meningitis research.

Conclusions:

  • Bacterial meningitis necessitates multifaceted treatment strategies.
  • Combining anti-inflammatory and neuroprotective therapies may improve patient outcomes.
  • Future research should focus on harnessing regenerative potential for brain repair after meningitis.
Keywords:
Streptococcus pneumoniaeanimal modelbacterial meningitisbrain injurydentate gyrusneurogenesisneuroinfectionneuroinflammation

More Related Videos

Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat08:27

Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat

Published on: October 29, 2014

11.7K
Induction of Leptomeningeal Cells Modification Via Intracisternal Injection05:55

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

Published on: May 7, 2020

9.3K

Related Concept Videos

Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
121
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K